Literature DB >> 21058727

Scytonemides A and B, cyclic peptides with 20S proteasome inhibitory activity from the cultured cyanobacterium Scytonema hofmanii.

Aleksej Krunic1, Armelle Vallat, Shunyan Mo, Daniel D Lantvit, Steven M Swanson, Jimmy Orjala.   

Abstract

Two cyclic peptides, scytonemides A (1) and B (2), were isolated from the cultured fresh water cyanobacterium Scytonema hofmannii (UTEX 1834) by bioassay-guided fractionation using a proteasome inhibition assay. The planar structures of the compounds were determined by a combination of MS and 1D and 2D NMR spectroscopy. The advanced Marfey's method was used to determine the absolute configuration of both peptides. Scytonemide A possesses an unusual imino linkage, while scytonemide B is a depsipeptide containing 3-hydroxyoctanoic acid in the macrocycle. Both isolates were evaluated for their inhibition of the 20S proteasome, and scytonemide A displayed an IC(50) value of 96 nM, while scytonemide B was inactive at 50 μM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21058727      PMCID: PMC3074188          DOI: 10.1021/np100600z

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  32 in total

1.  Isolation and structure determination of nostocyclopeptides A1 and A2 from the terrestrial cyanobacterium Nostoc sp. ATCC53789.

Authors:  T Golakoti; W Y Yoshida; S Chaganty; R E Moore
Journal:  J Nat Prod       Date:  2001-01       Impact factor: 4.050

2.  Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.

Authors:  M Groll; Y Koguchi; R Huber; J Kohno
Journal:  J Mol Biol       Date:  2001-08-17       Impact factor: 5.469

3.  A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.

Authors:  C García-Echeverría; P Imbach; D France; P Fürst; M Lang; A M Noorani; D Scholz; J Zimmermann; P Furet
Journal:  Bioorg Med Chem Lett       Date:  2001-05-21       Impact factor: 2.823

Review 4.  Back to the future with ubiquitin.

Authors:  Cecile M Pickart
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 5.  Proteasome inhibitors as therapeutic agents: current and future strategies.

Authors:  J G Delcros; M Baudy Floc'h; C Prigent; Y Arlot-Bonnemains
Journal:  Curr Med Chem       Date:  2003-03       Impact factor: 4.530

Review 6.  Targeting the proteasome as a therapeutic strategy against haematological malignancies.

Authors:  Robert Z Orlowski; Erik L Zeger
Journal:  Expert Opin Investig Drugs       Date:  2006-02       Impact factor: 6.206

Review 7.  Biogenetic diversity of cyanobacterial metabolites.

Authors:  Ryan M Van Wagoner; Allison K Drummond; Jeffrey L C Wright
Journal:  Adv Appl Microbiol       Date:  2007       Impact factor: 5.086

Review 8.  Panning for chemical gold: marine bacteria as a source of new therapeutics.

Authors:  Philip G Williams
Journal:  Trends Biotechnol       Date:  2008-11-18       Impact factor: 19.536

9.  Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor.

Authors:  S L Holloway; M Glotzer; R W King; A W Murray
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

10.  Trungapeptins A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula.

Authors:  Sutaporn Bunyajetpong; Wesley Y Yoshida; Namthip Sitachitta; Kunimitsu Kaya
Journal:  J Nat Prod       Date:  2006-11       Impact factor: 4.050

View more
  13 in total

Review 1.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

2.  Total Synthesis of Scytonemide A Employing Weinreb AM Solid-Phase Resin.

Authors:  Tyler A Wilson; Robert J Tokarski; Peter Sullivan; Robert M Demoret; Jimmy Orjala; L Harinantenaina Rakotondraibe; James R Fuchs
Journal:  J Nat Prod       Date:  2018-02-05       Impact factor: 4.050

3.  Biosynthetic Cyclization Catalysts for the Assembly of Peptide and Polyketide Natural Products.

Authors:  Maria L Adrover-Castellano; Jennifer J Schmidt; David H Sherman
Journal:  ChemCatChem       Date:  2021-01-28       Impact factor: 5.686

Review 4.  Natural products from thioester reductase containing biosynthetic pathways.

Authors:  Michael W Mullowney; Ryan A McClure; Matthew T Robey; Neil L Kelleher; Regan J Thomson
Journal:  Nat Prod Rep       Date:  2018-09-19       Impact factor: 13.423

5.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  Leslie N Aldrich; Joanna E Burdette; Esperanza Carcache de Blanco; Christopher C Coss; Alessandra S Eustaquio; James R Fuchs; A Douglas Kinghorn; Amanda MacFarlane; Brittney K Mize; Nicholas H Oberlies; Jimmy Orjala; Cedric J Pearce; Mitch A Phelps; Liva Harinantenaina Rakotondraibe; Yulin Ren; Djaja Doel Soejarto; Brent R Stockwell; Jack C Yalowich; Xiaoli Zhang
Journal:  J Nat Prod       Date:  2022-02-25       Impact factor: 4.803

6.  Application of high-field NMR spectroscopy for characterization and quantitation of submilligram quantities of isolated natural products.

Authors:  Aleksej Krunić; Jimmy Orjala
Journal:  Magn Reson Chem       Date:  2015-08-20       Impact factor: 2.447

7.  Draft Genome Sequence of the Terrestrial Cyanobacterium Scytonema millei VB511283, Isolated from Eastern India.

Authors:  Diya Sen; Mathu Malar Chandrababunaidu; Deeksha Singh; Neha Sanghi; Arpita Ghorai; Gyan Prakash Mishra; Madhavi Madduluri; Siba Prasad Adhikary; Sucheta Tripathy
Journal:  Genome Announc       Date:  2015-03-05

8.  Tricholides A and B and Unnarmicin D: New Hybrid PKS-NRPS Macrocycles Isolated from an Environmental Collection of Trichodesmium thiebautii.

Authors:  Matthew J Bertin; Alexandre F Roduit; Jiadong Sun; Gabriella E Alves; Christopher W Via; Miguel A Gonzalez; Paul V Zimba; Peter D R Moeller
Journal:  Mar Drugs       Date:  2017-06-30       Impact factor: 5.118

9.  Peptide Macrocyclization Inspired by Non-Ribosomal Imine Natural Products.

Authors:  Lara R Malins; Justine N deGruyter; Kevin J Robbins; Paul M Scola; Martin D Eastgate; M Reza Ghadiri; Phil S Baran
Journal:  J Am Chem Soc       Date:  2017-03-31       Impact factor: 15.419

10.  Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater Cyanobacterium Trichormus sp. UIC 10339.

Authors:  Shangwen Luo; Aleksej Krunic; Hahk-Soo Kang; Wei-Lun Chen; John L Woodard; James R Fuchs; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2014-08-04       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.